Reference
US Food & Drug Administration. Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin (TMV) Formulation: FDA Statement - Case of Hemorrhagic Occlusive Retinal Vasculitis Internet Document : 5 Oct 2017. Available from: URL: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm578743.htm -USA
Rights and permissions
About this article
Cite this article
Moxifloxacin/triamcinolone/vancomycin. Reactions Weekly 1673, 255 (2017). https://doi.org/10.1007/s40278-017-37343-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-37343-7